Nicholas A. Saccomano
Chief Executive Officer at OnKure, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Albert Bourla | M | 62 | 31 years | |
| Anthony D. Piscopio | M | - |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 13 years |
| R. Carruthers | M | 66 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 23 years |
| Douglas Giordano | M | 61 | 33 years | |
| Xuedong Liu | M | - |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 13 years |
| Douglas Lankler | M | 58 | 25 years | |
| Rady Johnson | M | 63 | 30 years | |
| Jerome Fox | M | - |
Think Bioscience, Inc.
 Think Bioscience, Inc. BiotechnologyHealth Technology Think Bioscience, Inc. is a company that is revolutionizing synthetic biology by utilizing living systems to create better medicines. The company is based in Boulder, CO and was founded by Jerome Fox, who has been the CEO since incorporation. The company's approach to drug discovery involves a combination of applied microbiology, enzymology, and computational science to develop small-molecule therapeutics for difficult-to-treat conditions. | - |
| Margaret M. Madden | F | - | 5 years | |
| Sally Susman | F | 62 | 17 years | |
| Charles M. Lillis | M | 82 |
SomaLogic Operating Co., Inc.
 SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | 11 years |
| Suzanne Johnson | F | 66 | 17 years | |
| Bryan Supran | M | - | 5 years | |
| John DeMattei | M | - |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | - |
| Annaliesa Anderson | M | - | 17 years | |
| Markus Green | M | - | 18 years | |
| Mike McDermott | M | 58 | 21 years | |
| Payal Sahni Becher | F | - | 27 years | |
| Guobao Zhao | M | - |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 7 years |
| Isaac Manke | M | 47 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 3 years |
| John DeYoung | M | 61 | 33 years | |
| Trevor Samuel Harris | M | 69 |
The Trustees of Columbia University in The City of New York
| 41 years |
| Andrew Phillips | M | 53 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 3 years |
| Suneet Varma | M | 55 | 23 years | |
| Joel Dudley | M | - |
Think Bioscience, Inc.
Think Bioscience, Inc. BiotechnologyHealth Technology Think Bioscience, Inc. is a company that is revolutionizing synthetic biology by utilizing living systems to create better medicines. The company is based in Boulder, CO and was founded by Jerome Fox, who has been the CEO since incorporation. The company's approach to drug discovery involves a combination of applied microbiology, enzymology, and computational science to develop small-molecule therapeutics for difficult-to-treat conditions. | 2 years |
| Barbara Dalton | M | 69 | 17 years | |
| Charles S. Laven | M | 72 |
The Trustees of Columbia University in The City of New York
| 43 years |
| Fintan R. Steele | M | - |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | 13 years |
| Philip Jeng | M | - |
Think Bioscience, Inc.
Think Bioscience, Inc. BiotechnologyHealth Technology Think Bioscience, Inc. is a company that is revolutionizing synthetic biology by utilizing living systems to create better medicines. The company is based in Boulder, CO and was founded by Jerome Fox, who has been the CEO since incorporation. The company's approach to drug discovery involves a combination of applied microbiology, enzymology, and computational science to develop small-molecule therapeutics for difficult-to-treat conditions. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Henry McKinnell | M | 81 | 8 years | |
| Jeffrey Kindler | M | 68 | 8 years | |
| David L. Snitman | M | 72 | 17 years | |
| Kyle A. Lefkoff | M | 64 | 21 years | |
| Dennis Ausiello | M | 78 | 13 years | |
| David Shedlarz | M | 75 | 31 years | |
| Charles Baum | M | 65 | 15 years | |
| Constance J. Horner | F | 82 | - | |
| George A. Lorch | M | 82 | 15 years | |
| Amy Schulman | F | 63 | 6 years | |
| Bahgat G. Sammakia | M | - |
The State University of New York
| 3 years |
| Maria Matesanz | F | - |
The Trustees of Columbia University in The City of New York
| 5 years |
| Joseph M. Danis | M | - | 10 years | |
| William R. Scott | M | - |
The State University of New York
| 4 years |
| Gary M. Holtzer | M | - |
The State University of New York
| 6 years |
| Tricia Haugeto | F | - | - | |
| George Iwanicki | M | - |
The State University of New York
The Trustees of Columbia University in The City of New York
| 7 years |
| Gwen A. Fyfe | M | 72 | 7 years | |
| Paul Fitzhenry | M | 64 | 4 years | |
| Robert John Murphy | M | - |
The State University of New York
| 6 years |
| Anders Klein | M | 71 |
The Trustees of Columbia University in The City of New York
| 6 years |
| Alan Levin | M | 62 | 20 years | |
| Jacob M. Plotsker | M | 56 | 16 years | |
| Andrew Robbins | M | 48 | 7 years | |
| John Orwin | M | 59 | 7 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Thomas J. Pardini | M | - |
The State University of New York
| 6 years |
| Curtis Oltmans | M | 60 | 2 years | |
| Evan King | M | - |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | - |
| Ranjeev Krishana | M | 50 | 7 years | |
| Cengiz Erol | M | - |
The State University of New York
| 5 years |
| Jonathan Emms | M | - | 20 years | |
| Steven Cohen | M | 70 |
The State University of New York
| 3 years |
| Yi Ning Zhao | M | 53 | 8 years | |
| Andrea N. Flynn | M | - | 1 years | |
| Jason Haddock | M | 54 | 3 years | |
| Jennifer Schroeder | F | - | 20 years | |
| Ron Squarer | M | 57 | 7 years | |
| Martin MacKay | M | 68 | 14 years | |
| Shalini Sharp | F | 49 | 2 years | |
| Max Holmes | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Gil van Lunsen | M | 81 | 17 years | |
| Byron Hewett | M | 66 |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | 4 years |
| Michael R. Jirousek | M | 65 | 5 years | |
| William Mundell | M | - |
The Trustees of Columbia University in The City of New York
| 4 years |
| David J. Horin | M | 56 | 1 years | |
| Charles H. Hill | M | 69 | 31 years | |
| Wyllie Cornwell | M | 76 | 23 years | |
| James Kilts | M | 76 | 13 years | |
| Robert N. Burt | M | 86 | 11 years | |
| Franklin Raines | M | 74 | 11 years | |
| William Herbert Gray | M | 82 | 13 years | |
| M. Anthony Burns | M | 81 | 25 years | |
| Michael Brown | M | 83 | 16 years | |
| Peter Corr | M | 76 | 6 years | |
| Dana George Mead | M | 88 | 12 years | |
| George Milne | M | 80 | 32 years | |
| Thomas W. Fry | M | 79 | 3 years | |
| Frank D'Amelio | M | 66 | 14 years | |
| Cheryl A. Hoffman-Bray | F | 66 |
The State University of New York
| 5 years |
| Mace Rothenberg | M | 67 | 13 years | |
| Bruce Eaton | M | 70 |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO. | 12 years |
| E. Walter van Valkenburg | M | - |
The Trustees of Columbia University in The City of New York
| 3 years |
| Olivier Brandicourt | M | 68 | 13 years | |
| John Moore | M | 59 | 15 years | |
| Paul G. Sedlack | M | - |
The State University of New York
| 6 years |
| Alexandra Kropotova | M | 51 | 5 years | |
| Mike Warner | M | - |
The State University of New York
| 4 years |
| Michael Watzky | M | - |
The State University of New York
| 4 years |
| Harold Gartner | M | - |
The State University of New York
| 4 years |
| Joanne M. Vitale | F | - |
The State University of New York
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nicholas A. Saccomano
- Personal Network
